Literature DB >> 24493091

Concordance for prognostic models with competing risks.

Marcel Wolbers1, Paul Blanche2, Michael T Koller3, Jacqueline C M Witteman4, Thomas A Gerds5.   

Abstract

The concordance probability is a widely used measure to assess discrimination of prognostic models with binary and survival endpoints. We formally define the concordance probability for a prognostic model of the absolute risk of an event of interest in the presence of competing risks and relate it to recently proposed time-dependent area under the receiver operating characteristic curve measures. For right-censored data, we investigate inverse probability of censoring weighted (IPCW) estimates of a truncated concordance index based on a working model for the censoring distribution. We demonstrate consistency and asymptotic normality of the IPCW estimate if the working model is correctly specified and derive an explicit formula for the asymptotic variance under independent censoring. The small sample properties of the estimator are assessed in a simulation study also against misspecification of the working model. We further illustrate the methods by computing the concordance probability for a prognostic model of coronary heart disease (CHD) events in the presence of the competing risk of non-CHD death.
© The Author 2014. Published by Oxford University Press.

Entities:  

Keywords:  C index; Competing risks; Concordance probability; Coronary heart disease; Prognostic models; Time-dependent AUC

Mesh:

Year:  2014        PMID: 24493091      PMCID: PMC4059461          DOI: 10.1093/biostatistics/kxt059

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  23 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  A competing risks analysis of bloodstream infection after stem-cell transplantation using subdistribution hazards and cause-specific hazards.

Authors:  Jan Beyersmann; Markus Dettenkofer; Hartmut Bertz; Martin Schumacher
Journal:  Stat Med       Date:  2007-12-30       Impact factor: 2.373

3.  Prognostic models with competing risks: methods and application to coronary risk prediction.

Authors:  Marcel Wolbers; Michael T Koller; Jacqueline C M Witteman; Ewout W Steyerberg
Journal:  Epidemiology       Date:  2009-07       Impact factor: 4.822

4.  Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks.

Authors:  Paul Blanche; Jean-François Dartigues; Hélène Jacqmin-Gadda
Journal:  Stat Med       Date:  2013-09-12       Impact factor: 2.373

5.  Quantifying the predictive accuracy of time-to-event models in the presence of competing risks.

Authors:  Rotraut Schoop; Jan Beyersmann; Martin Schumacher; Harald Binder
Journal:  Biom J       Date:  2011-01-14       Impact factor: 2.207

6.  Evaluating Random Forests for Survival Analysis using Prediction Error Curves.

Authors:  Ulla B Mogensen; Hemant Ishwaran; Thomas A Gerds
Journal:  J Stat Softw       Date:  2012-09       Impact factor: 6.440

7.  Evaluating the yield of medical tests.

Authors:  F E Harrell; R M Califf; D B Pryor; K L Lee; R A Rosati
Journal:  JAMA       Date:  1982-05-14       Impact factor: 56.272

Review 8.  The performance of risk prediction models.

Authors:  Thomas A Gerds; Tianxi Cai; Martin Schumacher
Journal:  Biom J       Date:  2008-08       Impact factor: 2.207

9.  Competing risks and the clinical community: irrelevance or ignorance?

Authors:  Michael T Koller; Heike Raatz; Ewout W Steyerberg; Marcel Wolbers
Journal:  Stat Med       Date:  2011-09-23       Impact factor: 2.373

10.  The Rotterdam Study: 2012 objectives and design update.

Authors:  Albert Hofman; Cornelia M van Duijn; Oscar H Franco; M Arfan Ikram; Harry L A Janssen; Caroline C W Klaver; Ernst J Kuipers; Tamar E C Nijsten; Bruno H Ch Stricker; Henning Tiemeier; André G Uitterlinden; Meike W Vernooij; Jacqueline C M Witteman
Journal:  Eur J Epidemiol       Date:  2011-08-30       Impact factor: 8.082

View more
  57 in total

1.  Competing risk is better than composite outcome to identify renal biomarker outcome.

Authors:  Matthieu Jamme; Jerome Lambert
Journal:  Kidney Int       Date:  2015-09       Impact factor: 10.612

2.  Fracture Risk Assessment in Long-term Care (FRAiL): Development and Validation of a Prediction Model.

Authors:  Sarah D Berry; Andrew R Zullo; Yoojin Lee; Vincent Mor; Kevin W McConeghy; Geetanjoli Banerjee; Ralph B D'Agostino; Lori Daiello; David Dosa; Douglas P Kiel
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2018-05-09       Impact factor: 6.053

3.  Should non-cardiovascular mortality be considered in the SCORE model? Findings from the Prevention of Renal and Vascular End-stage Disease (PREVEND) cohort.

Authors:  Biniyam G Demissei; Douwe Postmus; Mattia A Valente; Pim van der Harst; Wijk H van Gilst; Edwin R Van den Heuvel; Hans L Hillege
Journal:  Eur J Epidemiol       Date:  2014-11-07       Impact factor: 8.082

4.  Acute and Chronic Kidney Disease and Cardiovascular Mortality After Major Surgery.

Authors:  Tezcan Ozrazgat-Baslanti; Paul Thottakkara; Matthew Huber; Kent Berg; Nikolaus Gravenstein; Patrick Tighe; Gloria Lipori; Mark S Segal; Charles Hobson; Azra Bihorac
Journal:  Ann Surg       Date:  2016-12       Impact factor: 12.969

5.  Impact of Increasing Age on Cause-Specific Mortality and Morbidity in Patients With Stage I Non-Small-Cell Lung Cancer: A Competing Risks Analysis.

Authors:  Takashi Eguchi; Sarina Bains; Ming-Ching Lee; Kay See Tan; Boris Hristov; Daniel H Buitrago; Manjit S Bains; Robert J Downey; James Huang; James M Isbell; Bernard J Park; Valerie W Rusch; David R Jones; Prasad S Adusumilli
Journal:  J Clin Oncol       Date:  2016-10-31       Impact factor: 44.544

6.  Cardiovascular-Specific Mortality and Kidney Disease in Patients Undergoing Vascular Surgery.

Authors:  Matthew Huber; Tezcan Ozrazgat-Baslanti; Paul Thottakkara; Salvatore Scali; Azra Bihorac; Charles Hobson
Journal:  JAMA Surg       Date:  2016-05-01       Impact factor: 14.766

7.  Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation.

Authors:  Jonathan U Peled; Sean M Devlin; Anna Staffas; Melissa Lumish; Raya Khanin; Eric R Littmann; Lilan Ling; Satyajit Kosuri; Molly Maloy; John B Slingerland; Katya F Ahr; Kori A Porosnicu Rodriguez; Yusuke Shono; Ann E Slingerland; Melissa D Docampo; Anthony D Sung; Daniela Weber; Amin M Alousi; Boglarka Gyurkocza; Doris M Ponce; Juliet N Barker; Miguel-Angel Perales; Sergio A Giralt; Ying Taur; Eric G Pamer; Robert R Jenq; Marcel R M van den Brink
Journal:  J Clin Oncol       Date:  2017-03-15       Impact factor: 44.544

8.  Neutralizing Antibody-Mediated Response and Risk of BK Virus-Associated Nephropathy.

Authors:  Morgane Solis; Aurélie Velay; Raphaël Porcher; Pilar Domingo-Calap; Eric Soulier; Mélanie Joly; Mariam Meddeb; Wallys Kack-Kack; Bruno Moulin; Siamak Bahram; Françoise Stoll-Keller; Heidi Barth; Sophie Caillard; Samira Fafi-Kremer
Journal:  J Am Soc Nephrol       Date:  2017-10-17       Impact factor: 10.121

9.  Prospective Validation of Diagnostic Tumor Biomarkers in Men Treated With Radiotherapy for Prostate Cancer.

Authors:  Alan Pollack; Deukwoo Kwon; Gail Walker; Li Yan Khor; Eric M Horwitz; Mark K Buyyounouski; Radka Stoyanova
Journal:  J Natl Cancer Inst       Date:  2017-02-01       Impact factor: 13.506

10.  Value and limitations of the BAR-score for donor allocation in liver transplantation.

Authors:  Harald Schrem; Anna-Luise Platsakis; Alexander Kaltenborn; Armin Koch; Courtney Metz; Marc Barthold; Christian Krauth; Volker Amelung; Felix Braun; Thomas Becker; Jürgen Klempnauer; Benedikt Reichert
Journal:  Langenbecks Arch Surg       Date:  2014-09-14       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.